Evaluation of Indocyanine Green dye for sentinel lymph node biopsy in breast cancer
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 2: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2022/09/045719
- Lead Sponsor
- Department of Surgical Disciplines
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Upfront operable primary breast cancer measuring upto and including 5cm in maximum tumour dimension with clinically lymph node negative breast cancers (Tis, T1,T2-N0) undergoing upfront surgery
Consenting patient
Exclusion Criteria
Pregnant or lactating women
Patients who have received neo-adjuvant chemotherapy.
Patients with history of previous surgery of axilla or chest wall.
Patients with history of previous radiotherapy to the breast or axilla.
H/o hypersensitivity to any of the agents used.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method identification and comparison of sentinel lypmh node proportions using Indocyanine green with the standard radio colloid- methylene blue dye method.Timepoint: Baseline
- Secondary Outcome Measures
Name Time Method Procedure time of doing sentinel lymph node biopsy from time of skin incision to identification of sentinel lymph node in each group.Timepoint: Baseline